Funder: Center for Medicinal Cannabis Research
Due Dates (Anticipated): March 2027 (Letter of intent) | April 2027 (Full application)
Funding Amounts: Primary: up to $825,000 over three years | Pilot: up to $300,000 over two years
Summary: Supports primary and pilot studies of cannabis and cannabinoids’ therapeutic efficacy, adverse effects, and public health impacts.
Key Information: A California higher education or nonprofit research institution must lead; full applications require an invitation.
Description
The Center for Medicinal Cannabis Research (CMCR) at UC San Diego supports research on cannabis and cannabinoids as pharmacological agents for medical and psychiatric disorders, including their adverse effects and potential public health impacts. The program funds clinical research, basic science and animal studies with clear translational implications, and methods for detecting cannabinoids, endocannabinoids, and related substances.
Priorities include proof-of-principle findings that inform larger studies, scientific gaps identified by authoritative reviews, and promising new research directions. There is no predetermined ranking of eligible disorders. CMCR encourages work on under-researched conditions and cannabis constituents, psychoactive cannabinoids, plant-derived products or flower, and drugs affecting endocannabinoid pathways. Proposals leveraging other funding and institutions not previously represented in CMCR’s portfolio are encouraged; existing portfolio coverage does not exclude a topic.
